PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Zollinger-Ellison Syndrome D015043 1 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
Cryptorchidism D003456 2 associated lipids
Decapitation D049248 2 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Choroid Diseases D015862 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Wounds, Stab D014951 3 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Cryptococcosis D003453 3 associated lipids
Cholangitis D002761 3 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Dirofilariasis D004184 3 associated lipids
Airway Remodeling D056151 3 associated lipids
HTLV-I Infections D015490 3 associated lipids
Respiratory Sounds D012135 3 associated lipids
Ascariasis D001196 3 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Goiter D006042 4 associated lipids
Headache D006261 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Meningoencephalitis D008590 4 associated lipids
Coronavirus Infections D018352 4 associated lipids
Nasal Obstruction D015508 4 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Sneezing D012912 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Tauopathies D024801 6 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Thrombophilia D019851 6 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Folliculitis D005499 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Yang L et al. Peroxisome proliferator-activated receptor gamma and ligands inhibit surfactant protein B gene expression in the lung. 2003 J. Biol. Chem. pmid:12829715
Montuschi P et al. Exhaled leukotrienes and prostaglandins in COPD. 2003 Thorax pmid:12832671
Zahradka P et al. Activation of peroxisome proliferator-activated receptors alpha and gamma1 inhibits human smooth muscle cell proliferation. 2003 Mol. Cell. Biochem. pmid:12841350
Keelan JA et al. Cytokines, prostaglandins and parturition--a review. 2003 Placenta pmid:12842412
Chen CW et al. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. 2003 J. Immunol. pmid:12847270
Zhuang H et al. Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation. 2003 Ann. N. Y. Acad. Sci. pmid:12853315
Vosseler CA et al. Structural requirements of cyclopentenone prostaglandins to induce endothelial cell apoptosis. 2003 Biochem. Biophys. Res. Commun. pmid:12859958
Aoun P et al. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. 2003 Eur. J. Pharmacol. pmid:12860474
Zanoni G et al. First total synthesis of JS isoprostane. 2003 J. Org. Chem. pmid:12868940
Hirai H et al. Gene structure and functional properties of mouse CRTH2, a prostaglandin D2 receptor. 2003 Biochem. Biophys. Res. Commun. pmid:12878180
Khan E and Abu-Amer Y Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts. 2003 J. Lab. Clin. Med. pmid:12878983
Ceaser EK et al. Oxidized low-density lipoprotein and 15-deoxy-delta 12,14-PGJ2 increase mitochondrial complex I activity in endothelial cells. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12881207
Mendez M and LaPointe MC PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes. 2003 Hypertension pmid:12885795
Li L et al. Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. 2003 Gastroenterology pmid:12891549
Zanoni G et al. First enantioselective total synthesis of (8S,12R,15S)-prostaglandin J(2). 2003 J. Org. Chem. pmid:12895084
Kanaoka Y and Urade Y Hematopoietic prostaglandin D synthase. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895599
Nagata K and Hirai H The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895600
Powell WS A novel PGD(2) receptor expressed in eosinophils. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895601
Kabashima K and Narumiya S The DP receptor, allergic inflammation and asthma. 2003 Aug-Sep Prostaglandins Leukot. Essent. Fatty Acids pmid:12895602
Bishop-Bailey D and Warner TD PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist. 2003 FASEB J. pmid:12897060
Souza SC et al. TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. 2003 J. Cell. Biochem. pmid:12898507
Pestel S et al. Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate. 2003 Biochem. Pharmacol. pmid:12906929
Pritts EA et al. Peroxisome proliferator-activated receptor-gamma ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element. 2003 Fertil. Steril. pmid:12909507
Zanoni G et al. A --> J prostaglandin swap: a new tactic for cyclopentenone prostaglandin synthesis. 2003 J. Org. Chem. pmid:12919053
Tomita Y et al. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. 1992 Pigment Cell Res. pmid:1292020
Zhang M et al. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism]. 2003 Zhonghua Yi Xue Za Zhi pmid:12921638
Honda K et al. Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. 2003 J. Exp. Med. pmid:12925672
Farrow B et al. Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator. 2003 Surgery pmid:12947319
Kim EJ et al. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. 2003 J. Pharmacol. Exp. Ther. pmid:12966153
Collin M and Thiemermann C The PPAR-gamma ligand 15-deoxy(delta12,14) prostaglandin J2 reduces the liver injury in endotoxic shock. 2003 Eur. J. Pharmacol. pmid:12969773
Cuzzocrea S et al. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. 2003 Br. J. Pharmacol. pmid:12970094
Zhang M et al. Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis. 2003 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:12973930
Powell WS 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? 2003 J. Clin. Invest. pmid:12975467
Bell-Parikh LC et al. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. 2003 J. Clin. Invest. pmid:12975479
Shichijo M et al. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats. 2003 J. Pharmacol. Exp. Ther. pmid:12975488
Morii H and Watanabe Y A possible role of carbohydrate moieties in prostaglandin D2 and prostaglandin E2 receptor proteins from the porcine temporal cortex. 1992 Arch. Biochem. Biophys. pmid:1309289
Katz HR et al. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. 1992 J. Immunol. pmid:1309842
Picado C et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. 1992 Am. Rev. Respir. Dis. pmid:1309968
Yu SM et al. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. 1992 Biochem. Pharmacol. pmid:1310852
Froldi M et al. Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement. 1992 J. Neuroimmunol. pmid:1315794
Ellis JL and Undem BJ Antigen-induced enhancement of noncholinergic contractile responses to vagus nerve and electrical field stimulation in guinea pig isolated trachea. 1992 J. Pharmacol. Exp. Ther. pmid:1323657
Tamaoki J et al. Prostaglandin D2 increases Cl secretion across canine tracheal epithelium through cyclo-oxygenase stimulation and cAMP production. 1992 Acta Physiol. Scand. pmid:1323920
Ito S et al. Type-1 and type-2 astrocytes are distinct targets for prostaglandins D2, E2, and F2 alpha. 1992 Glia pmid:1324890
Liu H et al. Regulation of the surface expression of the platelet-activating factor receptor in IC-21 peritoneal macrophages. Effects of lipopolysaccharide. 1992 J. Biol. Chem. pmid:1328211
Molderings G et al. Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype. 1992 Br. J. Pharmacol. pmid:1330175
González-Utor AL et al. Cytochemical localization of K(+)-dependent p-nitrophenyl phosphatase and adenylate cyclase by using one-step method in human washed platelets. 1992 Histochemistry pmid:1330994
Björnsson OG et al. Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures: relationships to hepatic calcium metabolism. 1992 J. Lipid Res. pmid:1331281
Amici C et al. Inhibition of Sendai virus replication by delta 12-prostaglandin J2: induction of heat shock protein synthesis and alteration of protein glycosylation. 1992 Antiviral Res. pmid:1332600
Seregi A et al. Functionally diverse purinergic P2Y-receptors mediate prostanoid synthesis in cultured rat astrocytes: the role of ATP-induced phosphatidyl-inositol breakdown. 1992 Eicosanoids pmid:1333251
Knani J et al. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. 1992 J. Allergy Clin. Immunol. pmid:1334102